Press release from Companies: DanCann Pharma A/S announces its intention to carry out a directed issue of units

Press release from Companies: DanCann Pharma A/S acquires CannGros ApS and becomes market leader in the Danish market under the Pilot Programme with Medical Cannabis

Press release from Companies: DanCann Pharma A/S informs about the outcome of the TO1

Market Notices: Market Notice 187/21– Last day of trading in DanCann Pharma A/S’s subscription option DANCAN TO 1

Press release from Companies: DanCann Pharma A/S: Tetra Bio-Pharma Receives Positive Scientific Advice Assessment (SAA) Report for QIXLEEF™

Press release from Companies: DanCann Pharma A/S informs about warrants of series TO1

Press release from Companies: DanCann Pharma A/S publishes Q2-2021 report

Press release from Companies: DanCann Pharma A/S has reached a historic milestone with the first ever cannabis batch in BIOTECH PHARM1

Press release from Companies: DanCann Pharma A/S’ CEO and CCO have subscribed for shares and warrants in the directed issue

Press release from Companies: DanCann Pharma A/S has carried out a directed issue of shares of approx. DKK 6.375 million and warrants, in combination with obtaining a loan facility of SEK 13.7 million

Press release from Companies: Minutes from Extraordinary General Meeting in DanCann Pharma A/S

Press release from Companies: DanCann Pharma A/S: Tetra Bio-Pharma Accelerates REBORN1© Trial